Five-day nitrofurantoin beats single-dose fosfomycin for UTI

April 25, 2018

(HealthDay)—Five-day nitrofurantoin is associated with increased likelihood of clinical and microbiological resolution compared with single-dose fosfomycin among women with lower urinary tract infection (UTI), according to a study published online April 22 in the Journal of the American Medical Association.

Angela Huttner, M.D., from Geneva University, and colleagues conducted a involving 513 non-pregnant women with symptoms of lower UTI, a positive urine dipstick result, and no known colonization or previous infection with uropathogens resistant to the study antibiotics. Participants were randomized to oral nitrofurantoin for five days (255 ) or a single dose of oral (258 patients); 93 percent of patients completed the trial.

The researchers found that 70 and 58 percent of patients receiving nitrofurantoin and fosfomycin, respectively, achieved clinical resolution through day 28 (difference, 12 percent). Overall, 74 and 63 percent, respectively, had microbiologic resolution (difference, 11 percent). There were few adverse events and they were mainly gastrointestinal, most commonly nausea and diarrhea.

"Among women with uncomplicated UTI, five-day nitrofurantoin, compared with single-dose fosfomycin, resulted in a significantly greater likelihood of clinical and microbiologic resolution at 28 days after therapy completion," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further: Researchers describe role of novel mutations in fosfomycin resistance

More information: Abstract/Full Text
Editorial

Related Stories

Researchers describe role of novel mutations in fosfomycin resistance

April 23, 2018
Researchers identified novel chromosomal mutations and described their role in the development of resistance of Escherichia coli (E. coli) to broad-spectrum antibiotic fosfomycin, according to research presented at the 28th ...

Re-introducing an 'old' antibiotic may help fight multi-drug resistant bacteria

February 7, 2018
A new study indicates that the drug fosfomycin may be effective for treating multidrug-resistant bacterial infections. In most European countries, the oral formulation is only approved as a 3 gram single dose for the treatment ...

Antibiotics could be key to relieving chronic bladder pain

March 20, 2018
Antibiotics can successfully help rid a patient of chronic urinary tract infection symptoms. This is the finding of a new clinical study led by Sheela Swamy of University College London in the UK. The study in the International ...

Antibiotic commonly prescribed for bladder infections less effective than others

April 27, 2015
Older women with urinary tract infections who are taking the commonly prescribed antibiotic nitrofurantoin are more likely to experience treatment failure, resulting in a second antibiotic prescription or a hospital visit, ...

Fecal microbial transplant by oral capsule noninferior for CDI

November 29, 2017
(HealthDay)—For patients with recurrent Clostridium difficile infection (RCDI), fecal microbial transplantation (FMT) with oral capsules is noninferior to FMT by colonoscopy, according to a study published in the Nov. 28 ...

Prevalence of oral HPV infection higher for U.S. men

October 17, 2017
(HealthDay)—Oral human papillomavirus (HPV) infection and high-risk oral HPV infection are more common among men than women, according to a study published online Oct. 16 in the Annals of Internal Medicine.

Recommended for you

Green leafy vegetables may prevent liver steatosis

December 17, 2018
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake ...

Discovery of novel mechanisms that cause migraines

December 17, 2018
Researchers at CNRS, Université Côte d'Azur and Inserm have demonstrated a new mechanism related to the onset of migraine. They found how a mutation that causes dysfunction in a protein which inhibits neuronal electrical ...

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.